210 related articles for article (PubMed ID: 23669167)
1. Characteristics of NO cycle coupling with urea cycle in non-hyperammonemic carriers of ornithine transcarbamylase deficiency.
Nagasaka H; Yorifuji T; Egawa H; Inui A; Fujisawa T; Komatsu H; Tsukahara H; Uemoto S; Inomata Y
Mol Genet Metab; 2013 Jul; 109(3):251-4. PubMed ID: 23669167
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of endogenous nitric oxide synthesis in congenital urea cycle enzyme defects.
Nagasaka H; Tsukahara H; Yorifuji T; Miida T; Murayama K; Tsuruoka T; Takatani T; Kanazawa M; Kobayashi K; Okano Y; Takayanagi M
Metabolism; 2009 Mar; 58(3):278-82. PubMed ID: 19217439
[TBL] [Abstract][Full Text] [Related]
3. Hyperammonemic encephalopathy in a child with ornithine transcarbamylase deficiency due to a novel combined heterozygous mutations.
Gao J; Gao F; Hong F; Yu H; Jiang P
Am J Emerg Med; 2015 Mar; 33(3):474.e1-3. PubMed ID: 25227973
[TBL] [Abstract][Full Text] [Related]
4. Effects of arginine treatment on nutrition, growth and urea cycle function in seven Japanese boys with late-onset ornithine transcarbamylase deficiency.
Nagasaka H; Yorifuji T; Murayama K; Kubota M; Kurokawa K; Murakami T; Kanazawa M; Takatani T; Ogawa A; Ogawa E; Yamamoto S; Adachi M; Kobayashi K; Takayanagi M
Eur J Pediatr; 2006 Sep; 165(9):618-24. PubMed ID: 16703326
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthesis in ornithine transcarbamylase deficiency: possible involvement of low no synthesis in clinical manifestations of urea cycle defect.
Nagasaka H; Komatsu H; Ohura T; Sogo T; Inui A; Yorifuji T; Murayama K; Takayanagi M; Kikuta H; Kobayashi K
J Pediatr; 2004 Aug; 145(2):259-62. PubMed ID: 15289781
[TBL] [Abstract][Full Text] [Related]
6. Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes.
Marini JC; Erez A; Castillo L; Lee B
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1764-71. PubMed ID: 17925451
[TBL] [Abstract][Full Text] [Related]
7. Urea cycle disorders in Thai infants: a report of 5 cases.
Wasant P; Srisomsap C; Liammongkolkul S; Svasti J
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S720-31. PubMed ID: 12403252
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency.
Imoto K; Tanaka M; Goya T; Aoyagi T; Takahashi M; Kurokawa M; Tashiro S; Kato M; Kohjima M; Ogawa Y
BMC Gastroenterol; 2022 Mar; 22(1):144. PubMed ID: 35346058
[TBL] [Abstract][Full Text] [Related]
9. Prenatal treatment of ornithine transcarbamylase deficiency.
Wilnai Y; Blumenfeld YJ; Cusmano K; Hintz SR; Alcorn D; Benitz WE; Berquist WE; Bernstein JA; Castillo RO; Concepcion W; Cowan TM; Cox KL; Lyell DJ; Esquivel CO; Homeyer M; Hudgins L; Hurwitz M; Palma JP; Schelley S; Akula VP; Summar ML; Enns GM
Mol Genet Metab; 2018 Mar; 123(3):297-300. PubMed ID: 29396029
[TBL] [Abstract][Full Text] [Related]
10. The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency.
Maestri NE; Lord C; Glynn M; Bale A; Brusilow SW
Medicine (Baltimore); 1998 Nov; 77(6):389-97. PubMed ID: 9854602
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biochemical characteristics of patients with ornithine transcarbamylase deficiency.
Peng MZ; Li XZ; Mei HF; Sheng HY; Yin X; Jiang MY; Cai YN; Su L; Lin YT; Shao YX; Liu L
Clin Biochem; 2020 Oct; 84():63-72. PubMed ID: 32569589
[TBL] [Abstract][Full Text] [Related]
12. Differential utilization of systemic and enteral ammonia for urea synthesis in control subjects and ornithine transcarbamylase deficiency carriers.
Scaglia F; Marini J; Rosenberger J; Henry J; Garlick P; Lee B; Reeds P
Am J Clin Nutr; 2003 Oct; 78(4):749-55. PubMed ID: 14522733
[TBL] [Abstract][Full Text] [Related]
13. Hyperammonemia in a Woman with Late-onset Ornithine Transcarbamylase Deficiency.
Koya Y; Shibata M; Senju M; Honma Y; Hiura M; Ishii M; Matsumoto S; Harada M
Intern Med; 2019 Apr; 58(7):937-942. PubMed ID: 30449781
[TBL] [Abstract][Full Text] [Related]
14. Plasma alpha-ketoglutarate in urea cycle enzymopathies and its role as a harbinger of hyperammonemic coma.
Batshaw ML; Walser M; Brusilow SW
Pediatr Res; 1980 Dec; 14(12):1316-9. PubMed ID: 7208146
[TBL] [Abstract][Full Text] [Related]
15. Investigating neurological deficits in carriers and affected patients with ornithine transcarbamylase deficiency.
Sprouse C; King J; Helman G; Pacheco-Colón I; Shattuck K; Breeden A; Seltzer R; VanMeter JW; Gropman AL
Mol Genet Metab; 2014; 113(1-2):136-41. PubMed ID: 24881970
[TBL] [Abstract][Full Text] [Related]
16. Congenital hyperammonemic syndromes.
Shih VE
Clin Perinatol; 1976 Mar; 3(1):3-14. PubMed ID: 954343
[TBL] [Abstract][Full Text] [Related]
17. A simple screening method for heterozygous female patients with ornithine transcarbamylase deficiency.
Iijima H; Kubota M
Mol Genet Metab; 2022 Nov; 137(3):301-307. PubMed ID: 36252454
[TBL] [Abstract][Full Text] [Related]
18. Ornithine transcarbamylase deficiency unmasked because of gastrointestinal bleeding.
Trivedi M; Zafar S; Spalding MJ; Jonnalagadda S
J Clin Gastroenterol; 2001 Apr; 32(4):340-3. PubMed ID: 11276280
[TBL] [Abstract][Full Text] [Related]
19. Management of ornithine transcarbamylase deficiency in pregnancy.
Mendez-Figueroa H; Lamance K; Sutton VR; Aagaard-Tillery K; Van den Veyver I
Am J Perinatol; 2010 Nov; 27(10):775-84. PubMed ID: 20458665
[TBL] [Abstract][Full Text] [Related]
20. Blood levels of ammonia and nitrogen scavenging amino acids in patients with inherited hyperammonemia.
Tuchman M; Yudkoff M
Mol Genet Metab; 1999 Jan; 66(1):10-5. PubMed ID: 9973542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
